Evidence map›Paper›PMID 29543713›Full record

ReviewMolecules (Basel, Switzerland)2018

Therapeutic Perspectives of 8-Prenylnaringenin, a Potent Phytoestrogen from Hops.

Kateřina Štulíková, Marcel Karabín, Jakub Nešpor, Pavel Dostálek

Open access · goldAbstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed, 1 pooled it
10.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 1 synthesis or guideline pooled it, 98 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. A Comprehensive Study of Hops (Plants (Basel, Switzerland) · 2026
    Review
  5. Review
  6. Microbial production of xanthohumol driven by synthetic biology approaches.World journal of microbiology & biotechnology · 2026
    Review
  7. Review
  8. Article
  9. Review
  10. Hops (Nutrients · 2026
    Article
  11. ACS synthetic biology · 2025
    Article
  12. Pleiotropic regulatory mechanisms and targeted therapeutic prospects of Galectin-3 in aging-related diseases.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2025
    Review
  13. Review
  14. Review
  15. Article
  16. Molecules (Basel, Switzerland) · 2025
    Article
  17. Biology · 2025
    Article
  18. Article
  19. Anti-Influenza Virus Activity ofFoods (Basel, Switzerland) · 2023
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Kateřina ŠtulíkováDepartment of Biotechnology, University of Chemistry and Technology, Prague, Technická 5, 166 28 Prague 6, Czech Republic. stulikoa@vscht.cz.
Marcel KarabínDepartment of Biotechnology, University of Chemistry and Technology, Prague, Technická 5, 166 28 Prague 6, Czech Republic. marcel.karabin@vscht.cz.
Jakub NešporDepartment of Biotechnology, University of Chemistry and Technology, Prague, Technická 5, 166 28 Prague 6, Czech Republic. nesporj@vscht.cz.
Pavel DostálekDepartment of Biotechnology, University of Chemistry and Technology, Prague, Technická 5, 166 28 Prague 6, Czech Republic. pavel.dostalek@vscht.cz.ORCID 0000-0003-2973-1643
University of Chemistry and Technology, Prague · CZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hop (

Indexed as

Antineoplastic Agents, PhytogenicFemaleFlavanonesHumansHumulusMenopauseMolecular StructureOsteoporosis, PostmenopausalPhytoestrogens8-prenylnaringeninAntineoplastic Agents, PhytogenicFlavanonesPhytoestrogens8-prenylnaringeninhopsmenopausephytoestrogens

Identifiers

PMID29543713
PMCPMC6017581
OpenAlexW2791956299

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.